News

We provide the latest news
from the world of economics and finance

12 March
Victory Capital (VCTR) Sees 3% Sequential Rise in February AUM

Victory Capital Holdings, Inc. VCTR reported assets under management (AUM) of $164.9 billion for February 2024. This reflected a 2.9% rise from $160.2 billion as of Jan 31, 2024.

By asset class, VCTR’s U.S. Mid Cap Equity AUM grew 4.4% from the January level to $31.3 billion. The U.S. Small Cap Equity AUM of $15.7 billion increased 3%. The Global/Non-U.S. Equity AUM rose 3.4% to $17.1 billion. The U.S. Large Cap Equity AUM improved 5.5% to $13.5 billion.

Also, Victory Capital recorded $56.4 billion in Solutions, up 3.2% from January 2024. Money Market/Short-Term assets rose 1.1% from January 2024 to $3.3 billion. However, the Alternative Investments asset balance declined 1% on a sequential basis to $3.4 billion. Fixed Income AUM was $24.2 billion, which declined marginally from the prior month.

The sound positioning of VCTR's integrated multi-boutique business model in a rapidly evolving industry and the effectiveness of the distribution platform are likely to support its performance in the near term.

VCTR shares have gained 16.9% over the past six months compared with the industry's growth of 22.5%.

Image Source: Zacks Investment Research

Currently, Victory Capital carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Competitive Landscape

Cohen & Steers, Inc. CNS reported a preliminary AUM of $79.6 billion as of Feb 29, 2024. This reflected a marginal rise from the prior month's level.

The increase in CNS’s AUM was due to market appreciation of $1.2 billion, partly offset by net outflows of $683 million and distributions of $155 million.

Cohen & Steers recorded total institutional accounts of $31.5 billion at the end of February 2024, falling 1.5% from the January 2024-end level. Of the total institutional accounts, advisory accounts were $17.4 billion, while the rest were sub-advisory.

Invesco IVZ announced a preliminary AUM of $1,630.9 billion for February 2024, reflecting a 3% rise from the previous month-end.

IVZ delivered net long-term inflows of $1.8 billion in the month. Non-management fee-earning net inflows were $1.9 billion and money market net inflows were $3.5 billion. IVZ’s AUM was positively impacted by favorable market returns, which increased AUM by $42 billion. FX decreased AUM by $2.6 billion.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.